Kenvue Inc. (NYSE:KVUE) Stake Lessened by Crestwood Advisors Group LLC

Crestwood Advisors Group LLC cut its stake in Kenvue Inc. (NYSE:KVUE) by 3.1% during the 3rd quarter, HoldingsChannel reports. The fund owned 1,489,104 shares of the company’s stock after selling 48,244 shares during the period. Crestwood Advisors Group LLC’s holdings in Kenvue were worth $34,443,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in KVUE. Leo Wealth LLC grew its position in shares of Kenvue by 0.3% in the 3rd quarter. Leo Wealth LLC now owns 151,611 shares of the company’s stock worth $3,507,000 after acquiring an additional 481 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its position in shares of Kenvue by 6.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 8,400 shares of the company’s stock valued at $194,000 after acquiring an additional 492 shares in the last quarter. Wolff Wiese Magana LLC lifted its stake in Kenvue by 0.7% during the third quarter. Wolff Wiese Magana LLC now owns 76,999 shares of the company’s stock worth $1,781,000 after purchasing an additional 501 shares during the last quarter. Marathon Capital Management boosted its holdings in Kenvue by 0.3% in the second quarter. Marathon Capital Management now owns 149,699 shares of the company’s stock worth $2,722,000 after purchasing an additional 514 shares during the period. Finally, Manchester Capital Management LLC increased its stake in Kenvue by 80.8% during the first quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock valued at $25,000 after purchasing an additional 530 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

KVUE has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Royal Bank of Canada downgraded Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 target price for the company. in a research note on Tuesday, September 24th. JPMorgan Chase & Co. increased their price target on Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Piper Sandler boosted their price objective on Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Monday, September 23rd. Finally, Citigroup dropped their target price on Kenvue from $21.00 to $20.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus target price of $22.64.

Kenvue Price Performance

Shares of KVUE stock traded up $0.11 during midday trading on Tuesday, reaching $23.15. 406,851 shares of the company were exchanged, compared to its average volume of 18,024,801. The company’s 50 day moving average price is $22.55 and its two-hundred day moving average price is $20.45. The company has a market cap of $44.34 billion, a P/E ratio of 39.72, a PEG ratio of 2.97 and a beta of 1.36. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $23.55. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.68 and a current ratio of 0.99.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The firm had revenue of $4 billion during the quarter, compared to analyst estimates of $3.93 billion. During the same period last year, the company posted $0.32 EPS. The firm’s quarterly revenue was down .3% on a year-over-year basis. On average, sell-side analysts expect that Kenvue Inc. will post 1.08 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be issued a $0.205 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.54%. Kenvue’s payout ratio is currently 141.38%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.